A study found a twofold higher risk of MS for people with myelitis, or spinal cord inflammation, who have multiple lesions on ...

More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, ...

Transcriptomics of two prevailing models, cuprizone (CPZ) and lysophosphatidylcholine (LPC), reveal understanding of myelin loss and regeneration.

A new study compares CPZ and LPC models, creating a genetic roadmap to accelerate myelin regeneration therapies for Multiple ...

A new type of MRI scan may distinguish active from chronic MS lesions without the need for injected contrast dye.

Sclerotic lesions can be malignant or benign. They are usually localized to a single bone or area of your body. A malignant lesion is often cancerous, posing a risk to your health if it is not treated ...

Collaborating scientists at the Karolinska Institute and at Stockholm University used a technology called in situ sequencing (ISS) to help reveal at the cellular level how lesions in multiple ...

Summary: A multinational clinical trial demonstrated that a novel antibody, NG101, successfully preserves existing nerve tissue and accelerates the regression of spinal cord lesions following acute ...

Using advanced methodology, scientists in Sweden were able to reveal at the cellular level how lesions in multiple sclerosis develop. The new results are presented in the journal Cell by researchers ...